The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

Research reveals a sharp decline in both the effectiveness and duration of protection from prior infection post-Omicron, underscoring the need for updated vaccines to sustain immunity Study: ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Nearly 85% of people with long COVID had experienced ...

It’s that time of year: a thick, oppressive heat blankets everything, people huddle inside air-conditioned homes, offices, shops and cafes for respite—and COVID is surging again. Levels of SARS-CoV-2, ...

A research team has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19. The team has uncovered new insights into how ...

Two of the closest known relatives to SARS-CoV-2 — a pair of bat coronaviruses discovered by researchers in Laos — may transmit poorly in people despite being genetically similar to the ...

If a surface is contaminated with the SARS-CoV-2 virus, how long does it pose a risk of infection? Hosted by: Hank Green SciShow has a spinoff podcast! It's called SciShow Tangents. Support SciShow by ...

In a recent review published in the journal Cell Communication and Signaling, a team of researchers in Egypt and the United States explored the direct and indirect mechanisms of T lymphocyte-linked ...

Since the start of the COVID-19 pandemic, there has been controversy surrounding the origins of SARS-CoV-2. New research from the University of California, San Diego (UCSD), School of Medicine ...

UCSF researchers designed new drug candidates that potently block MPro, a viral enzyme that's crucial for SARS-CoV-2 replication. One of these drug candidates, AVI-4516, is shown (center) bound to the ...